Cornelis Alexander Maria De Haan

Title: Innovations of Cornelis Alexander Maria De Haan

Introduction

Cornelis Alexander Maria De Haan is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of immunology and vaccine development. With a total of 3 patents, his work focuses on innovative solutions for combating respiratory syncytial virus (RSV) infections.

Latest Patents

De Haan's latest patents include groundbreaking inventions such as "Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions." This patent describes heat-stable oligomeric recombinant polypeptides that present antigenic epitopes of the pre-fusion RSV F protein. These components are crucial for developing immunogenic compositions aimed at inducing immune responses against RSV infections. Another significant patent is "Immunogenic compositions in particulate form and methods for producing the same." This invention relates to vaccines based on native antigen oligomers, providing a novel approach to vaccine development.

Career Highlights

Cornelis De Haan is associated with Mucosis B.V., where he continues to advance his research and innovations. His work has been instrumental in the development of new immunological compositions that hold promise for effective vaccines.

Collaborations

De Haan collaborates with esteemed colleagues such as Petrus Josephus Marie Rottier and Bert Jan Haijema. Their combined expertise enhances the research and development efforts at Mucosis B.V.

Conclusion

Cornelis Alexander Maria De Haan's contributions to immunology and vaccine development are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science and improving public health.